Abstract:Post-transcriptional RNA modification is an emerging epigenetic control mechanism in cells that is important in many different cellular and organismal processes. N6-methyladenosine (m 6 A) is one of the most prevalent, prolific, and ubiquitous internal transcriptional alterations in eukaryotic mRNAs, making it an important topic in the field of Epigenetics. m 6 A methylation acts as a dynamical regulatory process that regulates the activity of genes and participates in multiple physiological processes, by supporting multiple aspects of essential mRNA metabolic processes, including pre-mRNA splicing, nuclear export, translation, miRNA synthesis, and stability. Extensive research has linked aberrations in m 6 A modification and m 6 A-associated proteins to a wide range of human diseases. However, the impact of m 6 A on mRNA metabolism and its pathological connection between m 6 A and other non-communicable diseases, including cardiovascular disease, neurodegenerative disorders, liver diseases, and cancer remains in fragmentation. Here, we review the existing understanding of the overall role of mechanisms by which m 6 A exerts its activities and address new discoveries that highlight m 6 A's diverse involvement in gene expression regulation. We discuss m 6 A deposition on mRNA and its consequences on degradation, translation, and transcription, as well as m 6 A methylation of non-coding chromosomal-associated RNA species. This study could give new information about the molecular process, early detection, tailored treatment, and predictive evaluation of human non-communicable diseases like cancer. We also explore more about new data that suggests targeting m 6 A regulators in diseases may have therapeutic advantages.

Recent developments of small molecules targeting RNA m<SUP>6</SUP>A modulators

Recent Developments of Small Molecules Targeting RNA M6a Modulators.

Rna N-6-Methyladenosine Methylation In Post-Transcriptional Gene Expression Regulation

The Emerging Molecular Mechanism of M6a Modulators in Tumorigenesis and Cancer Progression

The roles of m<SUP>6</SUP>A RNA modifiers in human cancer

N6-methyladenosine modifications: interactions with novel RNA-binding proteins and roles in signal transduction.

Advances in Biological Functions of RNA Chemical Modification M6a

The Roles of M6a RNA Modifiers in Human Cancer

N6-methyladenosine-mediated Gene Regulation and Therapeutic Implications.

Small molecule inhibitors targeting m6A regulators

Regulation of m6Am RNA modification and its implications in human diseases

The role of m<SUP>6</SUP>A modification in physiology and disease

Structural Insights into N 6 -Methyladenosine (m 6 A) Modification in the Transcriptome

RNA modification: mechanisms and therapeutic targets

Regulation and functions of non-m6A mRNA modifications

A Dynamic Reversible Rna N-6-Methyladenosine Modification: Current Status And Perspectives

Dynamic and reversible RNA N6‐methyladenosine methylation

RNA M6a Modification in Cancers: Molecular Mechanisms and Potential Clinical Applications.

Regulatory roles of N6-methyladenosine (m 6 A) methylation in RNA processing and non-communicable diseases

A Programmable System to Methylate and Demethylate N6-methyladenosine (m6a) on Specific RNA Transcripts in Mammalian Cells

Regulatory Roles of N6-methyladenosine (m6a) Methylation in RNA Processing and Non-Communicable Diseases